Risk factors

Large-Scale Study Details on Type 2 Diabetes and⁢ Metabolomics

A thorough metabolome-wide association study (MWAS) for incident ​Type ⁢2​ Diabetes (T2D) was conducted utilizing data from​ ten prospective ​cohorts, including the Nurses’ Health Study ‍(NHS), NHS2, health professionals Follow-Up Study (HPFS), Hispanic Community Health Study/Study of⁢ Latinos (SOL),​ Women’s Health ⁤Initiative (WHI), Atherosclerosis Risk ⁢in Communities (ARIC) study, Framingham Heart Study Offspring cohort (FHS), ⁢Multi-Ethnic Study of Atherosclerosis (MESA), Boston Puerto Rican Health Study (BPRHS), and the Prevención con Dieta Mediterránea Study (PREDIMED) [[3]].

study Participants & Data Collection: The study included a total​ of 6,890 participants from NHS, ‍3,692 from ⁢NHS2, 2,529 from HPFS, 2,821 from SOL, 1,392 from WHI, 1,288 white and 1,433 black participants from ARIC, 1,424 from FHS, 902 from MESA, 378 from ⁤BPRHS and ​885 from PREDIMED [[3]].Data collected included demographics, medical and family history, diet, lifestyle factors, and blood samples collected at baseline and during follow-up periods. Participants​ were required to have qualified‌ metabolomics ⁣data and be free of diabetes, cardiovascular disease, and cancer at⁢ the​ study’s start [[3]].

T2D Ascertainment: ⁢Incident T2D was ⁣defined as a new diagnosis during ⁢longitudinal follow-up in participants without⁣ diabetes at baseline.Diagnostic criteria varied slightly by cohort, utilizing fasting glucose levels, HbA1c measurements, medication use, ‌and self-reported diagnoses, adhering to guidelines from the National Diabetes Data Group and the american Diabetes Association [[3]].

Metabolomic Profiling & Harmonization: Metabolomic profiling was performed using LC–MS methods⁣ at the Broad Institute and Metabolon Inc. Data underwent rigorous⁣ quality control, including filtering for detection rates and coefficient of variation. A total of 407 metabolites were harmonized across cohorts for analysis, ensuring representation from multiple ⁣platforms and cohorts [[3]].

Statistical Analysis: Cox ‍and logistic regression models ‌were ​used to assess​ the ⁤association between metabolites and T2D risk, adjusted for various covariates including age, sex, lifestyle factors, ⁤BMI, and waist-to-hip ratio. Meta-analysis was performed to ⁣combine results across cohorts, and⁢ associations were considered statistically meaningful with a meta-analyzed false revelation rate (FDR) < 0.05 [[3]]. The novelty of identified associations was assessed by ⁣comparing findings to previously published literature.

Research​ suggests that plasma metabolomic signatures are linked to obesity and the risk of ⁤T2D [[2]],and can even ⁣demonstrate decent⁢ prediction performance for incident T2D risk [[3]]. Further analysis of the data is ongoing, with code examples available on ‍GitHub for⁣ figure generation [[1]].